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Background
Photon radiotherapy has undergone significant evolution with the development of new 
technologies and increased understanding of radiobiology (Mayles et al. 2007; Joiner and 
van der Kogel 2009). Over the last 15 years, one of the most promising refinements of 
this cancer treatment modality has been the development and functionalisation of high 
Z nanoparticles to target cancerous small animals/humans cell lines (Hainfeld et  al. 
2004, 2008; Jain et al. 2011). This class of novel nanomedicines, of which gold nanopar-
ticles (AuNP) are the most popular (Jain et  al. 2012), is thought to increase the local 
energy deposition and, in-turn, water radiolysis free-radical yield with a few 10–100 nms 
surrounding each NP (Jones et  al. 2010; McMahon et  al. 2011; Lechtman et  al. 2013; 
Lin et al. 2014; Sicard-Roselli et al. 2014; Tran et al. 2016). Whilst this technology is still 
in development and its exact biological action pathway is under intensive investigation, 
it has already been shown that NP radiosensitising agents utilised in conjunction with 
radiotherapy are able to provide increased tumour control and life expectancy in small 
animal models (Hainfeld et al. 2004, 2013; Joh et al. 2013; Xing et al. 2013).
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Development and experimental testing of functionalisation high Z NP radiosensitisers 
for a given cell line is a complex process which can take significant time and resources. 
Over the last decade, the scientific community has shifted towards exploring the poten-
tial of a developed high Z NP radiosensitiser for photon radiotherapy through mechanis-
tic characterisation utilising radiation transport codes such as EGSnrc (Kawrakow 2000), 
Geant4/Geant4-DNA (Agostinelli et  al. 2003;   Allison et  al. 2006, 2016; Incerti et  al. 
2010; Bernal et  al. 2015), MCNPX (Pelowitz 2005) and PENELOPE (Baro et  al. 1995; 
Salvat et  al. 2006). Originally, the scientific community tried to predict the increased 
effect of high Z NPs through the use of a variety of dose enhancement figures of merit 
(DEFM) known via a number of different names. All of these DEFMs were based on the 
assumption that expected biological outcome of cells/tumours could be described via 
the ratio of dose deposition with and without high Z NP doping under uniform photon 
irradiation (Cho 2005; Roeske et al. 2007; Ngwa et al. 2010). This underlying assumption 
neglects two of the key physical factors which determine the action of high Z NP within 
cells under photon irradiation: (1) the increased localised energy deposition within the 
first few 10–100 nms of the NP surface (Jones et al. 2010; McMahon et al. 2011; Lecht-
man et al. 2013; Lin et al. 2014; Sicard-Roselli et al. 2014; Tran et al. 2016), and (2) NP 
distribution within the irradiated cells (Lechtman et al. 2013; Brun et al. 2009; Coulter 
et  al. 2012; Cui et  al. 2014; McQuaid et  al. 2016). An alternative to these DEFMs, the 
local effect model (LEM) (Scholz and Kraft 1996, 2004) was first applied 5 years ago to 
photon radiotherapy in an attempt to account for one of these two key physical factors: 
the increased dose localisation within the first few 10–100 nm of the NP surface (McMa-
hon et al. 2011). Two years later, Lechtman et al. (2013) proposed an extension specifi-
cally for AuNPs, the AuNP radiosensitisation predictive (ARP) model, in an attempt to 
account for both of these two physical factors neglected via DEFMs (Lechtman et  al. 
2013). Both these models were shown to be able to predict specific cell survival fraction 
behaviour under photon irradiation observed through clonogenic assay (McMahon et al. 
2011; Lechtman et al. 2013).
The following work builds on the success of the LEM and presents a new experimen-
tally benchmarked framework capable of interpolating NP-enhanced photon-irradiated 
clonogenic cell survival fraction measurements as a function of NP concentration. This 
LEM-based framework was developed to fill in the existing gaps of individual cell line 
response as a function of NP concentration under photon irradiation to assist the scien-
tific community in planning future pre-clinical trials of high Z nanoparticle-enhanced 
photon radiotherapy.
Local effect model‑based interpolation framework
The developed LEM-based interpolation framework is intended to be used in conjunc-
tion with the existing wealth of available experimental survival fraction data for high Z 
NP-undoped and NP-doped specific cell line studies (Jain et  al. 2012). At a minimum 
each of these studies possesses a set of in vitro clonogenic assays of a cell line undoped 
and doped with high Z NPs that have been irradiated by a gamma-/X-ray source with a 
known energy spectra. The following derivation outlines how these data can be interpo-
lated as a function of NP concentration, up to a maximum concentration corresponding 
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to the NP-doped cell line survival data, within the LEM formalism for a given cell line/
incident photon energy spectra combination.
The LEM can be constructed utilising three main assumptions. First, the survival frac-
tion of a cellular colony/system under photon irradiation (SF) can be described via a lin-
ear-quadratic response:
where α and β are characteristics of the target cell line, and D is the mean dose deliv-
ered to the entire volume of the cellular colony/system (McMahon et al. 2011; Douglas 
and Fowler 1976). Second, that cell “inactivation”, e.g. cell death, can be attributed to the 
creation of a number of lethal lesions within a sensitive small sub-cellular volume such 
as the cell nucleus (Scholz and Kraft 1996, 2004). Here, a lethal lesion is defined as the 
local modification of DNA generated from the direct and indirect action of ionisation 
radiation (i.e. a double-strand break). And finally, any contribution of sub-lethal damage 
at distances larger than the order of a few microns is ignored as it is assumed that there 
is no interaction between distant sites (Scholz and Kraft 1996, 2004).
Using these assumptions, it is possible to describe the survival fraction for a cell under 
photon irradiation in terms of the mean number of lethal lesions (〈N (D)〉):
and inversely:
Within each cell under photon irradiation, lethal lesions are generated inhomogeneously 
and the probability of their creation is a direct function of local dose deposition. These 
properties mean that total lesion number in a cell’s sensitive region can be given via inte-
gration over its whole volume:
where d(x, y, z) is the local dose deposited for a given position within the sensitive region 
of the cell and Vsens is the total volume of the sensitive region of interest.
For a cellular colony/system doped with a concentration of high Z NPs (C), the LEM 
framework allows for the total local dose deposition within the sensitive region of the 
cell to be separated into two parts:
where dU(x, y, z) and dNP(C , x, y, z) are the dose distributions generated within the sen-
sitive region from the direct interaction of radiation with the bulk cell and high Z NPs, 
respectively. With this separation, Eq. 4 can be expressed as:
(1)SF[D] = exp
(
−αD − βD2
)
(2)SF[D] = exp(−�N (D)�)
(3)�N (D)� = − log(SF[D]).
(4)
�Ntotal(D)� =
∫
− log(SF[d(x, y, z)])
Vsens
dV
= α
∫
d(x, y, z)
Vsens
dV + β
∫
d(x, y, z)2
Vsens
dV
(5)d(x, y, z) = dU(x, y, z)+ dNP(C , x, y, z)
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In addition, over the range of validity of dose in the linear-quadratic model, 1–6  Gy 
(Joiner and van der Kogel 2009), the probability of two energy deposits within dU(x, y, z) 
and dNP(C , x, y, z) at the same location can be assumed to be negligible. Therefore, their 
product term in Eq. 6 can be set to zero such that:
where 〈NU (D)〉 is the mean number of lethal lesion generated via photon interaction 
within an undoped cellular region, and 〈NNP(C ,D)〉 is the mean number of lethal lesion 
generated via high Z NP action within the doped cellular region. Here, 〈NNP(C ,D)〉 
encompasses the lethal lesion generated from direct photon interaction with NPs, sec-
ondary electron generated from photon–cellular medium interaction collisions with 
NPs, and secondary electron/photons generated from photon–NP interactions colli-
sion with other NPs. If the spatial distribution of NP uptake within the cell line remains 
approximately constant with concentration, then from a mechanistic perspective the 
mean number of lethal lesions generated from these effects can be scaled with average 
NP density up to a critical saturation threshold (McKinnon et  al. 2016). Under these 
assumptions, Eq. 7 can be manipulated to yield:
where 〈Ntotal(C0,D)〉 is the mean number of lethal lesions for a given dose D at a known 
reference concentration C0. With this, Eq. 7 can be expressed as:
(6)
�Ntotal(C ,D)� = α
∫
dU(x, y, z)+ dNP(C , x, y, z)
Vsens
dV
+ β
∫ (
dU(x, y, z)+ dNP(C , x, y, z)
)2
Vsens
dV
= α
∫
dU(x, y, z)
Vsens
dV + β
∫
dU(x, y, z)
2
Vsens
dV
+ α
∫
dNP(C , x, y, z)
Vsens
dV + β
∫
dNP(C , x, y, z)
2
Vsens
dV
+ 2β
∫
dU(x, y, z)× dNP(C , x, y, z)
Vsens
dV .
(7)
�Ntotal(C ,D)� ≈ α
∫
dU(x, y, z)
Vsens
dV + β
∫
dU(x, y, z)
2
Vsens
dV
+ α
∫
dNP(C , x, y, z)
Vsens
dV + β
∫
dNP(C , x, y, z)
2
Vsens
dV
= �NU (D)� + �NNP(C ,D)�
(8)
�NNP(C ,D)� = �Ntotal(C ,D)� − �NU(D)�
≈
C
C0
(�Ntotal(C0,D)� − �NU(D)�)
(9)
�Ntotal(C ,D)� = �NU(D)� +
C
C0
(�Ntotal(C0,D)� − �NU(D)�)
= − log(SFU[D])−
C
C0
(
log(SFtotal[C0,D])− log(SFU[D])
)
=
(
αU +
C
C0
�α
)
D +
(
βU +
C
C0
�β
)
D2
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where �α = αtotal(C0)− αU and �β = βtotal(C0)− βU. The final form of the interpola-
tion framework is then given via the substitution of Eq. 9 into Eq. 2:
Multiple concentration and incident photon spectra experimental 
benchmarking
Experimental benchmarking of the develop framework was undertaken using the only 
published multiple concentration and incident photon spectra experimental NP radio-
sensitisation study; the Ph.D. thesis of Rahman, RMIT University (Australia) (Rahman 
2010). Within this thesis the radiosensitisation of 1.9  nm AuNP (Nanoprobes Inc., 
Yaphank, NY 11980, USA) in Bovine Aortic Endothelial Cells (BAECs) under superfi-
cial kilovoltage X-ray was studied as a surrogate model for human endothelial cells. The 
radiosensitivity of four different AuNP concentrations (0, 0.25, 0.5 and 1.0  mMol/L) 
was explored in triplicate trials for three different kilovoltage X-ray spectra (80, 100 
and 150  kVp) delivered via a superficial X-ray therapy (SXRT) machine (Therapax 3 
Series, Pantak Inc., Branford, CT, USA) at the William Buckland Radiotherapy Centre 
(The Alfred Hospital, Australiaρ) (Rahman 2010). Each of these 12 different cell survival 
curves were composed of a control and five different dose irradiations that were assessed 
via a CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega Corp., 
Madison, Wisconsin). The mean survival fraction, uncertainty (± cell survival standard 
deviation) and fitted linear-quadratic response of the control (0  mMol/L) and highest 
concentration (1 mMol/L) data for all three different incident photon spectra are pre-
sented in Fig. 1. Each data set’s linear-quadratic response was fitted using least-squares 
regression in Python, restricting α and β to positive values, and their corresponding 
parameters can be found in Table 1. Further information regarding experimental proce-
dure, AuNP cellular localisation, AuNP cytotoxicity, cell viability, and cell mobility can 
be found in Rahman’s thesis (Rahman 2010).
The developed interpolation framework was applied to the control and AuNP-doped 
fitted linear-quadratic parameters contained in Table  1 to predict the BAEC survival 
fraction response as a function of dose for AuNP concentrations of 0.25 and 0.5 mMol/L 
for all three different incident photon spectra. Figure  2 presents these predicted data 
sets in conjunction with the 0.25 and 0.5  mMol/L experimental data from Rahman 
(2010). Comparison of the predicted response and experimental data sets shows that 
the developed interpolation framework is able to accurately predict the BAEC survival 
fraction response to within experimental uncertainties for all dose points in the 100 and 
150 kVp data sets. For the 80 kVp data, the predicted survival fraction response is within 
experimental uncertainty for three data points out of six in both the tested 0.25 and 
0.5 mMol/L cases. This poor performance of the developed interpolation framework at 
80 kVp can be attributed to the high level of statistical fluctuation within the base 80 kVp 
experimental data seen in Fig. 1.
Figure 3 presents the percentage difference between the control and highest concen-
tration experimental data sets with respect to their fitted linear-quadratic responses 
shown in Fig. 1. In this figure, it can be seen that the level of difference in the 80 kVp data 
exceeds both the 100 and 150 kVp data sets. However, the magnitude of the observed 
(10)SF[C ,D] = exp
(
−
(
αU +
C
C0
�α
)
D −
(
βU +
C
C0
�β
)
D2
)
.
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difference in Fig. 2 cannot be explained via Fig. 3 alone. Figure 4 presents the percent-
age difference of the 0.25 and 0.5 mMol/L experimental data in Fig. 2 with respect to 
their fitted linear-quadratic responses obtained utilising the same protocols as Table 1. 
The level of difference in the 80 kVp data again exceeds the 100 and 150 kVp data sets, 
and their combined respective magnitudes with those seen in Fig. 3 correlate with the 
observation deviation between the experimental and predicted 80  kVp data seen in 
Fig. 2. These observations indicate that the performance of the developed interpolation 
framework is directly dependent on the quality of input data, a characteristic common 
to many interpolative frameworks.  
Discussion
A LEM-based framework capable of interpolating NP-enhanced photon irradiated 
clonogenic cell survival fraction measurements as a function of NP concentration was 
developed and experimentally benchmarked for 1.9  nm AuNP-doped BAECs under 
Fig. 1 Bovine aortic endothelial cell (BAEC) cell survival fraction as a function of administered 1.9 nm AuNP 
concentration (0 and 1.0 mMol/L), dose and incident photon spectra (80, 100 and 150 kVp) obtained using 
a superficial X-ray therapy (SXRT) machine (Therapax 3 Series, Pantak Inc., Branford, CT, USA) at the William 
Buckland Radiotherapy Centre (The Alfred Hospital, Australia) (Rahman 2010). Data were sourced from the 
Ph.D. thesis of Rahman (2010)
Table 1 Linear‑quadratic parameters for each cell survival curve shown in Fig. 1
Each data set was fitted using least‑squares regression in Python whilst restricting α and β to positive values
Photon spectra (kVp) Concentration (mMol/L) α  (Gy−1) β (Gy−2)
80 0.00 0.00 ± 1.66 × 10−2 1.96 × 10−2 ± 4.36 × 10−3
1.00 1.58 × 10−2 ± 4.64 × 10−2 8.10 × 10−2 ± 1.67 × 10−2
100 0.00 2.52 × 10−2 ± 3.69 × 10−3 1.30 × 10−3 ± 9.39 × 10−4
1.00 3.47 × 10−2 ± 3.36 × 10−3 9.04 × 10−3 ± 9.64 × 10−4
150 0.00 0.00 ± 3.95 × 10−3 7.14 × 10−3 ± 1.08 × 10−3
1.00 2.03 × 10−2 ± 4.44 × 10−3 1.34 × 10−2 ± 1.26 × 10−3
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superficial kilovoltage X-ray irradiation. It was illustrated that the performance of the 
developed framework is directly dependent on the quality of input experimental data. 
However, further inspection of the percentage differences between experimental 
data and their respective fitted linear-quadratic responses shown in Figs. 3 and 4 also 
illustrates that there are limits to which statistical fluctuation can be suppressed via a 
linear-quadratic fitting approach. Another observation with respect to linear-quad-
ratic response fitting and the present work is that the resultant α and β values must be 
Fig. 2 Predicted and extracted experimental bovine aortic endothelial cell (BAEC) survival fractions for 0.25 
and 0.5 mMol/L administered 1.9 nm AuNP under 80, 100 and 150 kVp superficial X-ray irradiation. The pre-
dicted data sets were calculated utilising Eq. 10 and cell survival fitted linear-quadratic parameters presented 
in Table 1
Fig. 3 The percentage difference between the control and highest concentration experimental data sets 
with respect to their fitted linear-quadratic responses shown in Fig. 1. The observed level of difference in the 
80 kVp data exceeds both the 100 and 150 kVp data
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restricted to being positive. Without these restrictions, the predicted survival fraction 
response would be incorrectly estimated. For example, if either value of αtotal(C0) or 
βtotal(C0) was negative, it would result in an underestimation of the predicted survival 
fraction response. Whereas if either value of αU or βU was negative, it would result in an 
overestimation of the predicted survival fraction response. Either of these outcomes in 
the context of high Z NP-enhanced photon radiotherapy treatment planning is unaccep-
table as it would pose a significant risk to the patient.
The LEM-based interpolation framework presented in this work was developed to fill 
in the existing gaps within individual cell line response data as a function of NP concen-
tration under photon irradiation. These interpolated data sets will be used in conjunc-
tion with another predictive framework that has been developed at Queen’s University 
Belfast which expresses the enhanced biological response of NP-doped cells/systems 
in terms of standard photon radiotherapy dose. These two predictive frameworks form 
the basis of a novel methodology which is intended to assist the scientific community 
in planning future pre-clinical trials of high Z NP-enhanced photon radiotherapy. Fur-
ther work is presently underway to illustrate the potential of these two frameworks in 
the context of AuNP-enhanced breast cancer MV photon radiotherapy as a medical 
exemplar.
Conclusion
A LEM-based framework capable of interpolating NP-enhanced photon irradiated 
clonogenic cell survival fraction measurements as a function of NP concentration was 
developed and experimentally benchmarked for 1.9  nm AuNP-doped BAECs under 
superficial kilovoltage X-ray irradiation. For three different superficial kilovoltage X-ray 
spectra (80, 100 and 150 kVp), the BAEC survival fraction response was predicted for 
two different AuNP concentrations (0.25 and 0.5 mMol/L). Two of the three predicted 
Fig. 4 The percentage difference of the 0.25 and 0.5 mMol/L experimental data in Fig. 2 with respect to their 
fitted linear-quadratic responses obtained utilising the same protocols as Table 1. The level of difference in 
the 80 kVp data exceeds both the 100 and 150 kVp data as it did for the control and highest concentration 
experimental data sets seen in Fig. 3
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spectra data sets (100 and 150 kVp) were within experimental uncertainties for all data 
points, whereas the other data set (80 kVp) was within experimental uncertainties half 
of the time. The observed poor performance for the 80 kVp data set was found to be due 
to a high level of statistical fluctuation within the base data and this illustrated that the 
performance of developed interpolation framework is directly dependent on the quality 
of the input experimental data. It is anticipated that this interpolation framework will 
serve as an important tool for planning future pre-clinical and clinical trials of high Z 
NP-enhanced photon radiotherapy.
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